Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report

Pujol-Gimenez, J, de Heredia, FP, Angel Idoate, M, Airley, R, Pilar Lostao, M and Evans, AR (2015) Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report. Journal of Cancer, 6 (2). pp. 139-143. ISSN 1837-9664

WarningThere is a more recent version of this item available.
Glut-12 paper.pdf - Published Version

Download (1MB) | Preview


Background: Recent studies proposed GLUT12 to be a major glucose transporter involved in the glycolytic metabolism of cancer cells.

Methods: GLUT12 expression was determined by immunohistochemistry in a selection of cancer
cell lines and a tumour spheroid model.

Results: GLUT12 expression was high in A549 and RH-36; low in HT29; and absent in NB-EB cancer cell lines. GLUT12 expression was located in the necrotic centre of HT29 spheroids, which
is characterised by anaerobic metabolism.
Conclusion: The data supports the involvement of GLUT12 in the glycolytic metabolism of cancer
cells and therefore, its potential as a novel therapeutic target for cancer treatment.

Item Type: Article
Uncontrolled Keywords: Science & Technology; Life Sciences & Biomedicine; Oncology; GLUT12; Cancer cell lines; Spheroid; Immunohistochemistry; Glycolytic metabolism; FACILITATIVE GLUCOSE TRANSPORTERS; HUMAN PLACENTA; TUMOR HYPOXIA; EXPRESSION; P53; LOCALIZATION; TISSUES; AGENTS; CELLS
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy & Biomolecular Sciences
Publisher: Ivyspring International Publisher
Related URLs:
Date Deposited: 21 May 2015 10:28
Last Modified: 04 Sep 2021 14:42
DOI or ID number: 10.7150/jca.10429
URI: https://researchonline.ljmu.ac.uk/id/eprint/425

Available Versions of this Item

View Item View Item